What amount sold does Starget Pharma Inc. report in Form D filings?

The latest linked filings report $16.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Starget Pharma Inc.'s most recent SEC filing?

Starget Pharma Inc.'s most recent Form D filing was on 2026-02-03.

How many investors does Starget Pharma Inc. have?

The most recent Form D filing lists 29 investor(s).

Starget Pharma Inc.

CIK: 0002108969·Biotechnology·SHREVEPORT, LA

Reported Sold

$16,373,737

Total Filings

Identified Offerings

Last Filed

Feb 3, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Feb 3, 2026Form D — New notice

Reported sold: $16,373,737 · Target: $22,158,515

Rule 506(b)·29 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

N/A

Amendment Rate

Latest reported sold across 1 identified offering

$16,373,737

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Sigal Kalmanson Cusnir

Executive Officer

Appears on 1 filing

Ronen Kalmanson

Director

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 3, 2026	New	$22,158,515	$16,373,737	29

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

28bio, Inc.

Biotechnology

Offering target: $8,524,945

Filed Oct 29, 2026